BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20581103)

  • 1. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome.
    Kiencke S; Handschin R; von Dahlen R; Muser J; Brunner-Larocca HP; Schumann J; Felix B; Berneis K; Rickenbacher P
    Eur J Heart Fail; 2010 Sep; 12(9):951-7. PubMed ID: 20581103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for heart disease in diabetic subjects.
    Fang ZY; Schull-Meade R; Leano R; Mottram PM; Prins JB; Marwick TH
    Am Heart J; 2005 Feb; 149(2):349-54. PubMed ID: 15846276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
    de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
    Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine nonischemic left ventricular dysfunction: a model of chronic human cardiomyopathy.
    Nishijima Y; Feldman DS; Bonagura JD; Ozkanlar Y; Jenkins PJ; Lacombe VA; Abraham WT; Hamlin RL; Carnes CA
    J Card Fail; 2005 Oct; 11(8):638-44. PubMed ID: 16230269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus.
    Somaratne JB; Whalley GA; Bagg W; Doughty RN
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):109-25. PubMed ID: 18095911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.
    Goldberg LR; Jessup M
    Circulation; 2006 Jun; 113(24):2851-60. PubMed ID: 16785351
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for left ventricular systolic dysfunction: the use of B-type natriuretic peptide.
    Freitag MH; Vasan RS
    Heart Fail Monit; 2003; 4(2):38-44. PubMed ID: 14724717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of electrocardiographic myocardial infarction screening criteria in patients with nonischemic cardiomyopathies.
    Shah BR; Lin C; Maynard C; Bart B; Selvester RH; Shaw LK; O'Connor C; Wagner GS
    Am Heart J; 1998 Aug; 136(2):314-9. PubMed ID: 9704696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brain natriuretic peptide (BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance].
    Logeart D; Gambert A; Beyne P; Guiti C; Geyer C; Bourgoin P; Alonso C; Ennezat PV; Gourgon R; Cohen-Solal A
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):523-8. PubMed ID: 12555377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
    Lim TK; Hayat SA; Gaze D; Celik E; Collinson P; Senior R
    Am J Cardiol; 2007 Sep; 100(5):870-5. PubMed ID: 17719336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.
    Löwbeer C; Gustafsson SA; Seeberger A; Bouvier F; Hulting J
    Scand J Clin Lab Invest; 2004; 64(7):667-76. PubMed ID: 15513324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension.
    Conen D; Zeller A; Pfisterer M; Martina B
    Am J Cardiol; 2006 Jan; 97(2):249-52. PubMed ID: 16442372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.